Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells

Polyamine levels decrease with menopause; however, little is known about the mechanisms regulated by menopause. In this study, we found that among the genes involved in the polyamine pathway, polyamine oxidase (<i>PAOX</i>) mRNA levels were the most significantly reduced by treatment wit...

Full description

Bibliographic Details
Main Authors: Jin Hyung Kim, Seung-Taek Lee
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/14/7521
_version_ 1797446661943853056
author Jin Hyung Kim
Seung-Taek Lee
author_facet Jin Hyung Kim
Seung-Taek Lee
author_sort Jin Hyung Kim
collection DOAJ
description Polyamine levels decrease with menopause; however, little is known about the mechanisms regulated by menopause. In this study, we found that among the genes involved in the polyamine pathway, polyamine oxidase (<i>PAOX</i>) mRNA levels were the most significantly reduced by treatment with 17β-estradiol in estrogen receptor (ESR)-positive MCF-7 breast cancer cells. Treatment with 17β-estradiol also reduced the PAOX protein levels. Treatment with selective ESR antagonists and knockdown of ESR members revealed that estrogen receptor 2 (ESR2; also known as ERβ) was responsible for the repression of PAOX by 17β-estradiol. A luciferase reporter assay showed that 17β-estradiol downregulates <i>PAOX</i> promoter activity and that 17β-estradiol-dependent PAOX repression disappeared after deletions (−3126/−2730 and −1271/−1099 regions) or mutations of activator protein 1 (AP-1) binding sites in the <i>PAOX</i> promoter. Chromatin immunoprecipitation analysis showed that ESR2 interacts with AP-1 bound to each of the two AP-1 binding sites. These results demonstrate that 17β-estradiol represses <i>PAOX</i> transcription by the interaction of ESR2 with AP-1 bound to the <i>PAOX</i> promoter. This suggests that estrogen deficiency may upregulate PAOX expression and decrease polyamine levels.
first_indexed 2024-03-09T13:44:45Z
format Article
id doaj.art-ee441e3f67cf4f84a09adc13c7147332
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T13:44:45Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ee441e3f67cf4f84a09adc13c71473322023-11-30T21:03:09ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-07-012314752110.3390/ijms23147521Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer CellsJin Hyung Kim0Seung-Taek Lee1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, KoreaDepartment of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, KoreaPolyamine levels decrease with menopause; however, little is known about the mechanisms regulated by menopause. In this study, we found that among the genes involved in the polyamine pathway, polyamine oxidase (<i>PAOX</i>) mRNA levels were the most significantly reduced by treatment with 17β-estradiol in estrogen receptor (ESR)-positive MCF-7 breast cancer cells. Treatment with 17β-estradiol also reduced the PAOX protein levels. Treatment with selective ESR antagonists and knockdown of ESR members revealed that estrogen receptor 2 (ESR2; also known as ERβ) was responsible for the repression of PAOX by 17β-estradiol. A luciferase reporter assay showed that 17β-estradiol downregulates <i>PAOX</i> promoter activity and that 17β-estradiol-dependent PAOX repression disappeared after deletions (−3126/−2730 and −1271/−1099 regions) or mutations of activator protein 1 (AP-1) binding sites in the <i>PAOX</i> promoter. Chromatin immunoprecipitation analysis showed that ESR2 interacts with AP-1 bound to each of the two AP-1 binding sites. These results demonstrate that 17β-estradiol represses <i>PAOX</i> transcription by the interaction of ESR2 with AP-1 bound to the <i>PAOX</i> promoter. This suggests that estrogen deficiency may upregulate PAOX expression and decrease polyamine levels.https://www.mdpi.com/1422-0067/23/14/752117β-estradiol (E2)polyaminepolyamine oxidase (PAOX)estrogen receptor (ESR)activator protein 1 (AP-1)
spellingShingle Jin Hyung Kim
Seung-Taek Lee
Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
International Journal of Molecular Sciences
17β-estradiol (E2)
polyamine
polyamine oxidase (PAOX)
estrogen receptor (ESR)
activator protein 1 (AP-1)
title Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
title_full Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
title_fullStr Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
title_full_unstemmed Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
title_short Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
title_sort polyamine oxidase expression is downregulated by 17β estradiol via estrogen receptor 2 in human mcf 7 breast cancer cells
topic 17β-estradiol (E2)
polyamine
polyamine oxidase (PAOX)
estrogen receptor (ESR)
activator protein 1 (AP-1)
url https://www.mdpi.com/1422-0067/23/14/7521
work_keys_str_mv AT jinhyungkim polyamineoxidaseexpressionisdownregulatedby17bestradiolviaestrogenreceptor2inhumanmcf7breastcancercells
AT seungtaeklee polyamineoxidaseexpressionisdownregulatedby17bestradiolviaestrogenreceptor2inhumanmcf7breastcancercells